Brief: Hemcheck Sweden Q1 Operating Loss Widens To SEK 3.7 Mln
May 7 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* Q1 OPERATING LOSS SEK 3.7 MILLION VERSUS LOSS SEK 2.8
MILLION
YEAR AGO
* Q1 OPER REV SEK 181,174
Source text for Eikon: ID:nWkr37GzTc
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln